SIGHT SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 69.22K shares, a 96.82% increase year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 463.96K shares, a 3473.06% increase year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 95.66K shares, a 145.69% increase year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 637.16K shares, a 207.65% increase from fiscal 2024.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 207.10K shares, a 44.05% decline from fiscal 2023.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 370.13K shares, a 45.85% decline from fiscal 2022.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 683.48K shares, a 43.12% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 628.84K shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 69.22K shares 10-Q · filed 2026-05-06 | 671.21K shares derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | 463.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 637.16K shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 95.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 186.18K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 42.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 129.46K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 35.17K shares 10-Q · filed 2025-05-08 | 109.31K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 12.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | 207.10K shares 10-K · filed 2025-03-07 |
| 2024-09-30 | 38.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 398.86K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 22.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | 420.66K shares derived: sum of 4 quarters · filed 2024-08-02 |
| 2024-03-31 | 132.96K shares 10-Q · filed 2024-05-06 | 455.35K shares derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-12-31 | 204.74K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 370.13K shares 10-K · filed 2024-03-13 |
| 2023-09-30 | 60.74K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 267.33K shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 56.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 470.77K shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 47.74K shares 10-Q · filed 2023-05-08 | 645.57K shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | 101.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 683.48K shares 10-K · filed 2023-03-16 |
| 2022-09-30 | 264.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | |
| 2022-06-30 | 231.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | |
| 2022-03-31 | 85.64K shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 477.56K shares 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |